Denali Therapeutics (NasdaqGS:DNLI) 2026 Conference March 09, 2026 03:40 PM ET Company ParticipantsKatie Peng - Chief Commercial OfficerRyan Watts - CEOConference Call ParticipantsMarc Goodman - Senior Managing Director and Senior Research AnalystMarc GoodmanOkay. Thanks for joining us, everybody. I'm Marc Goodman, one of the biopharma analysts at Leerink Partners. We are lucky to have Denali Therapeutics. We have Ryan Watts, who's the CEO of the company, and we have Katie Peng, who is the Chief Commercial ...